Bicycle Therapeutics (BCYC) Cash from Operations (2018 - 2026)

Bicycle Therapeutics (BCYC) has 9 years of Cash from Operations data on file, last reported at 49606000.0 in Q2 2026.

• Quarterly Cash from Operations rose 31.85% year-over-year to 49606000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 206050000.0 (up 1.12% YoY) and the FY2025 annual result came in at 249675000.0, down 51.57% from the prior year.
• Cash from Operations climbed to 49606000.0 in Q2 2026, from 65925000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 34096000.0 in Q2 2023 to a low of 86370000.0 in Q1 2025.
• A 5-year average of 37592722.22 and a median of 42229500.0 in 2024 frame the typical range for Cash from Operations.
• Annual changes were most pronounced in 2023 — Cash from Operations surged 244.9% — and 2024, when it tumbled 3786.05%.
• Tracing BCYC's Cash from Operations over 5 years: stood at 30309000.0 in 2022, then slumped by 56.02% to 47288000.0 in 2023, then surged by 80.13% to 9396000.0 in 2024, then slumped by 105.9% to 19346000.0 in 2025, then tumbled by 156.41% to 49606000.0 in 2026.
• The last three Cash from Operations figures came in at 49606000.0 (Q2 2026), 65925000.0 (Q1 2026), and 19346000.0 (Q4 2025), per Business Quant data.